HER2 Positive Gastric Carcinomas and Their Clinico-Pathological Characteristics

BACKGROUND: HER2 protein expression in gastric carcinoma, in correlation with existing, acknowledged prognostic factors which include the parameters that determine the TNM stage of the disease, could become the basis for ongoing research in the field of molecular targeted and personalised therapy. A...

Descripción completa

Detalles Bibliográficos
Autores principales: Ognjenovic, Ljubomir, Trajkovski, Gjorgji, Gjoshev, Stojan, Shumkovski, Aleksandar, Dzambaz, Darko, Hadzi-Manchev, Dragan, Volcevski, Goce, Fildishevski, Igor, Nikolova, Dafina, Petrushevska, Gordana, Janevska, Vesna, Janevski, Vlado
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Republic of Macedonia 2018
Materias:
Basic Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6062279/
https://www.ncbi.nlm.nih.gov/pubmed/30087720
http://dx.doi.org/10.3889/oamjms.2018.280

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6062279/
https://www.ncbi.nlm.nih.gov/pubmed/30087720
http://dx.doi.org/10.3889/oamjms.2018.280

Ejemplares similares